REG - Plant Health Care - Exercise of Options
RNS Number : 7314PPlant Health Care PLC20 October 2021
The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.
Plant Health Care plc
("Plant Health Care" or "the Company")
Exercise of Options, Issue of Equity, Director / PDMR Shareholding
and Total Voting Rights
Plant Health Care, a leading provider of novel patent-protected biological products to global agricultural markets, announces that on 20 October 2021 Christopher Richards, Chief Executive Officer, exercised options (the 'Options') awarded under the Company's 2017 Employee Share Option Plan (the 'Plan').As announced on 7 October 2020, the Company had awarded 3,250,000 Options to Christopher Richards with an exercise price of 1p per ordinary share in the Company (the 'Ordinary Shares') under the Plan that vest upon the earlier of: (a) the date of a Change of Control; or (b) upon satisfaction of the Performance-Based Requirement. The Performance-Based Requirement in respect of 70% of the Options (rounded to the nearest whole number) is that no Option may be exercised until the date on which the arithmetic mean closing price of the Ordinary Shares over 30 consecutive trading dates after the date of grant has exceeded 15p per Share. This criteria was achieved earlier this year and Dr Richards has now decided to exercise 2,275,000 Options.
Of the 2,275,000 Ordinary Shares to be issued (the 'New Ordinary Shares') following the exercise of the Options, Christopher Richards has sold 879,042 Ordinary Shares at an aggregate price of £100,146.06, being enough Ordinary Shares to cover the exercise price and associated tax liabilities in respect of the Ordinary Shares issued. Following these transactions, Dr Richards is interested in 4,370,973 Ordinary Shares representing 1.43% of the issued share capital of the Company.
Application for admission of the New Ordinary Shares to trading on AIM ('Admission') has been made and dealings in the New Ordinary Shares are expected to commence at 8.00 a.m. on 26 October 2021. The New Ordinary Shares will rank pari-passu with the Company's existing issued Ordinary Shares.
Total voting rights
Following Admission, the Company will have 304,662,482 Ordinary Shares in issue with no shares held in treasury. This is the total number of voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Enquiries
Plant Health Care plc
+1 919 926 1600
Richard Webb - Chairman
Arden Partners plc - Nomad and Joint Broker
John Llewellyn-Lloyd / Antonio Bossi
+44 (0)20 7614 5900
Cenkos Securities plc - Joint Broker
Neil McDonald / Peter Lynch
+44 (0) 20 7391 8900
Company website: www.planthealthcare.com
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Dr Christopher Richards
2
Reason for the notification
a)
Position/status
Chief Executive Officer
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Plant Health Care plc
b)
LEI
213800KBQPJZ2FM8QH27
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Options over Ordinary Shares of 1p each
GB00B01JC540b)
Nature of the transaction
Sale of Shares following exercise of options
c)
Price(s) and volume(s)
Price(s)
Volume(s)
11.45p
879,042
d)
Aggregated information
-
Aggregated volume
-
Price
879,042
£100,146.06e)
Date of the transaction
20.10. 2021
f)
Place of the transaction
AIM, London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDIOEBRBDGDGDDGBG
Recent news on Plant Health Care
See all newsREG - Plant Health Care - Holding(s) in Company
AnnouncementREG - Plant Health Care - Holding(s) in Company
AnnouncementREG - Plant Health Care - Trading Update
AnnouncementREG - Plant Health Care - Approval of Harpinαβ in Belgium
AnnouncementREG - Plant Health Care - Plant Health Care--China Distribution with AMVAC
Announcement